-
Loading metrics
Pyrazinamide clearance is impaired among HIV/tuberculosis patients with high levels of systemic immune activation
- Christopher Vinnard,
- Shruthi Ravimohan,
- Neo Tamuhla,
- Jotam Pasipanodya,
- Shashikant Srivastava,
- Chawangwa Modongo,
- Nicola M. Zetola,
- Drew Weissman,
- Tawanda Gumbo,
- Gregory P. Bisson
x
- Published: November 2, 2017
- https://doi.org/10.1371/journal.pone.0187624